VALIANTLAB — Valiant Laboratories Income Statement

0.000.00%

Last trade - 00:00

Basic MaterialsSpeculativeSmall CapSucker Stock

Annual income statement for Valiant Laboratories, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2022 March 31st	2023 March 31st	2024 March 31st
Period Length:	12 M	12 M	12 M
Source:	ARS	PROSPECTUS	ARS
Standards:	IAS	IAS	IAS
Status:	Final	Final	Final
Revenue
Total Revenue	2,082	3,339	1,821
Cost of Revenue
Gross Profit	407	566	138
Selling / General / Administrative Expenses
Depreciation and Amortization
Other Operating Expenses
Total Operating Expenses	1,797	3,004	1,924
Operating Profit	285	335	-104
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	302	381	-7.7
Provision for Income Taxes
Net Income After Taxes	227	290	3.2
Net Income Before Extraordinary Items
Net Income	227	290	3.2
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	227	290	3.2
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	14	8.91	0.084
Dividends per Share